Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,207 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06888960RecruitingEarly Phase 1
Testing CC312 for people with autoimmune diseases
This early-phase study tests a new drug called CC312 in patients with certain autoimmune diseases like lupus, myositis, scleroderma, rheumatoid arthritis, immune thrombocytopenia, or autoimmune hemolytic anemia. The goal is to see if it's safe and how the body handles it.
Tianjin, ChinaAges 18 years+ - NCT06883526RecruitingPhase 1/Phase 2
ZG005 plus gecacitinib for lymphoma that has returned or not responded
This trial tests a combination of two drugs, ZG005 and gecacitinib, for people with lymphoma that has come back or hasn't gotten better with prior treatment. The goal is to see if this combination can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18 years+ - NCT06890273Recruiting
Study of durvalumab and olaparib for endometrial cancer
This study looks at how well two drugs, durvalumab and olaparib, work together after initial chemotherapy for advanced or recurrent endometrial cancer. It may help patients who have not had many treatment options before.
AmbergAges 18–130 - NCT06887348Recruiting
Long-term safety study for prior RP1, RP2, or RP3 patients
This study checks the long-term safety of patients who have already received RP1, RP2, or RP3 treatment in a previous study. It helps doctors understand any side effects that may appear over time.
La Jolla, CaliforniaAges 18 years+ - NCT06882135RecruitingPhase 1
Testing an experimental drug for advanced solid tumors
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT06880198Recruiting
Study of Impact app for advanced melanoma patients on immunotherapy
This trial is testing whether a digital tool called Impact can help support patients with advanced melanoma who are receiving immunotherapy drugs like Nivolumab, alone or in combination. The goal is to see if the app helps manage treatment and improve outcomes.
NaplesAges 18 years+ - NCT06889493RecruitingPhase 1
SVV-001 plus immunotherapy for neuroendocrine cancers
This trial tests a new virus-based treatment (SVV-001) combined with two immunotherapy drugs (nivolumab and ipilimumab) for people with advanced neuroendocrine cancers that have gotten worse after at least one prior treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Miami, FloridaAges 18 years+ - NCT06885541Recruiting
Measuring internal tremors in Parkinson's patients
This study uses a device on your body to detect internal tremors (tiny vibrations you may feel inside) in Parkinson's disease. It helps researchers understand these tremors better and compare them to people without Parkinson's.
Toulouse, OccitanieAges 18–80 - NCT06887205Recruiting
Lymphatic reconstruction after melanoma surgery: a pilot study
This trial tests a surgical procedure called immediate lymphatic reconstruction for melanoma patients who need lymph node removal. It aims to reduce swelling and improve recovery.
Houston, TexasAges 18 years+ - NCT06888817RecruitingPhase 3
Bevacizumab vs steroids for brain radiation injury
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
AmsterdamAges 18 years+ - NCT06883136Enrolling by invitation
Sintilimab plus chemo for elderly advanced lung cancer
This trial tests a combination of the immunotherapy drug sintilimab plus standard chemotherapy (platinum-based doublet) as the first treatment for older adults (60–80) with advanced non-small cell lung cancer that does not have certain gene mutations. The goal is to see if this approach works better than chemotherapy alone.
Jinan, ShandongAges 60–80 - NCT06888557Recruiting
Smartphone help for COPD: improve quality of life
This trial tests a smartphone-based program to help people with COPD manage their condition and feel better. You will use WhatsApp or WeChat to get support and track your activity.
Hong Kong, Hong KongAges 40 years+ - NCT06881927RecruitingPhase 4
Reducing anti-rejection meds in ICU for kidney transplant patients
This study tests whether quickly reducing your anti-rejection medicines during a life-threatening ICU stay can help your kidneys recover and improve your overall outcome. It is for kidney transplant recipients with septic shock or severe breathing failure.
StrasbourgAges 18 years+ - NCT06888050RecruitingPhase 4
Study of new diabetes pill versus metformin for new type 2 diabetes
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
Hangzhou, ZhejiangAges 18–75 - NCT06883747RecruitingEarly Phase 1
Study of BMS-986504 for recurrent brain tumor
This trial tests an experimental drug, BMS-986504, for people with recurrent glioblastoma (a type of brain cancer). The drug targets a specific genetic change in the tumor. It aims to see if the drug can help shrink or slow the tumor.
Phoenix, ArizonaAges 18 years+ - NCT06888063RecruitingPhase 2
Chemo pump into the liver for bile duct cancer that can be surgically removed
This trial tests whether giving extra chemotherapy directly to the liver through a small pump (called HAIP) before or after surgery can improve outcomes for patients with bile duct cancer inside the liver. It is for patients whose cancer is considered removable by surgery.
Rotterdam, South HollandAges 18 years+ - NCT06881992RecruitingPhase 3
Testing ersodetug for low blood sugar from neuroendocrine tumors
This study tests a new medicine called ersodetug in people whose neuroendocrine tumors cause dangerously low blood sugar that standard treatments can't control. If you need IV sugar or nutrition for at least a week, this trial may offer a new option to help manage your blood sugar.
Chicago, IllinoisAges 18 years+ - NCT06885515Enrolling by invitation
Telomere length in Israeli patients with fibrotic ILD
This study looks at the length of telomeres (a part of your DNA) in people with fibrotic interstitial lung disease (ILD) in Israel. It aims to understand how telomere length relates to this condition and may help guide future care.
AshkelonAges 18 years+ - NCT06887777RecruitingPhase 2
Testing RAVICTI for PDH deficiency in young people
This study tests if a medicine called Glycerol Phenylbutyrate (RAVICTI) is safe and helpful for children and young adults with a specific type of PDH deficiency, a rare genetic condition affecting energy use. If you qualify, you may get a new treatment option.
Paris, FranceAges 2–25 - NCT06880302Recruiting
Male infertility research for sperm and tissue samples
This trial collects sperm, semen, and testicular tissue samples from men undergoing fertility treatments to build a biobank for research. If you are providing such samples for freezing, you can help advance understanding of male infertility.
Basking Ridge, New JerseyAges Any age - NCT06888427Recruiting
Sleep after surgery for adults
This study looks at how sleep changes for adults after surgery under general anesthesia. Researchers want to understand patients' experiences with sleep during recovery.
Nice, Alpes-MaritimesAges 18 years+ - NCT06887387Recruiting
Wearable devices to monitor Long QT Syndrome
This study tests whether wearable devices can help monitor Long QT Syndrome, a heart condition. It aims to make tracking your heart easier and more convenient than clinic visits.
LondonAges 18 years+ - NCT06883448Recruiting
Home monitoring for pulmonary fibrosis
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
AmsterdamAges 18 years+ - NCT06889389Recruiting
Education and exercise for neck pain relief
This study tests if combining education with exercise can reduce pain and improve function for people with non-specific neck pain (pain not caused by a specific injury or disease). Participants will learn about their condition and do guided exercises.
Elche, AlicanteAges 18–65
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,207 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.